Mankind Group Mankind Group

Our Business

Mankind Pharma - Ensuring care for all of Mankind

Mankind Group

Mankind

Mankind’s journey began in 1995 with only 53 Medical Representatives and Managers. Today, Mankind is one of the top 5 leading pharmaceutical companies in India with a dedicated field force of over 2138 professionals. Mankind Pharma achieved a turnover of Rs. 14944 million for the fiscal year 2017-18 with a growth of 9%. Mankind Pharma contributed 30% in Mankind Group of Company’s sales which was Rs. 50060 million in 2017-18 and aiming for Rs. 15600 million in 2019-20.

Mankind Pharma focuses on a variety of therapeutic segments such as Cardiovascular, Antibiotics, Gastro-intestinal, Anti-allergic, Anti-fungal, Nutritional, NSAIDs, Ortho and Gynaecological. Every day 64 Lacs Indians consume Mankind's cardiac care products. Mankind has launched many innovative and successful products such as Placida, Zolahart, Hergrace, Overzyme in the Indian market and economical brands like Nurokind, Moxikind, Telmikind, Cefakind, and Rabekind.

The total net worth of Mankind Pharma’s products are as follows: Moxikind(Rs. 1984 million), Telmikind (Rs. 1801 million), Amlokind (Rs. 1472 million), Nurokind (Rs. 1123 million), Zenflox (Rs. 888 million), and Cefakind (Rs. 788 million). Mankind Pharma gives equal emphasis to quality and compliance. All our manufacturing processes adhere to GMP guidelines to ensure excellent quality standards. Technology and Research and Development play a vital role in creating quality health care products. Mankind manufactures a wide range of dosage forms including oral solids, oral liquids, soft gelatine capsules and injectables. It also creates products that require specialized conditions such as controlled-release pharmaceutical products, controlled humidity and temperature conditions etc.

Mankind Pharma’s mission is to improve the quality of life, to continue to be recognized as a reliable provider of health care products and nurture innovation that leads to collective excellence.

Lifestar

Lifestar Pharma began in 2005 as the first separate financial entity of Mankind with a base of Rs. 90 million. By 2017-18, Lifestar achieved remarkable success with a turnover of Rs. 7000 million. Lifestar Pharma aims to achieve a turnover of Rs. 7950 million by 2019-20. Lifestar Pharma has always aimed at providing world-class products in the public domain. Major therapeutic focus areas of Lifestar are Gynecology, Dermatology, Ophthalmology & Pediatrics. Some of Lifestar Pharma’s brands are Gudcef, Asthakind, Terbinaforce, Argipreg, Ketostar, Hairbless, Ovabless, Biopreg-F, Urikind KM Sachet and Entromax. Lifestar Pharma is a pioneer in Anti-Fungal therapy and strives to spread awareness against fungal diseases.

Spreading its wings into Gynaecology, Lifestar pharma also performs its CSR activities and has hundreds of kids suffering from Cleft lip and Palate to recover.

Lifestar Pharma continues to be a low-cost warrior. All products are affordable as compared to other competitor brands. Lifestar carved a niche for itself by entering rural markets and slashing drug prices, making it one of the fastest-growing pharmaceutical companies within a decade. Ketostar, Letrohope, Asthakind are some of the products of Lifestar pharma that are cost-effective.

The product spectrum encompasses brands which have been launched in India for the first time and is one of the main drivers of growth for Lifestar Pharma.

Lifestar Pharma’s strategic vision of serving life with products of outstanding quality at affordable prices has transformed the pharmaceutical industry towards new ways of thinking.

Magnet Labs

Mankind acquired Magnet Labs Pvt Ltd in 2007 with a base of only Rs. 20 million, within 10 years reached Rs. 2300 million and aims to achieve a turnover of Rs. 3200 million by the year 2019-20. Magnet strives to bring affordable medicines to areas where a majority of patients needs are unmet.

Magnet Mankind is committed to achieving customer satisfaction, to provide products and services of the highest quality and to manage operations with responsibility for the safety of the environment. A well-trained and qualified field force of 1200 is engaged in developing specialised and chronic therapies across the country. The diversity of products, technologies, markets and people at Magnet Mankind inspire new ideas and ways of addressing the changing health needs.

Magnet Mankind covers all major therapy areas, including Anti-bacterial, Nutritional, Gastro-intestinal, Pain management, Anti-allergic and Cough. Its stringent adherence to quality, extensive marketing reach and premium packaging have enabled products to emerge as top brands in their respective segments. Some of its top-selling products are Brutacef, Nurokind Forte, Brutaflam, Hepakind, Gut-OK, Menohelp, Ubinext-LC, Rifastop, Ranidom-RD, Protijump, Gudgesic, Histakind & Magnatuss. Magnet aspires to create a healthier world with a vision of providing quality products at affordable prices has transformed into new ways of thinking, a new journey for growth and medical breakthroughs for patients.
Magnet Labs ambitions are:
  • Creating and surpassing new performance standards
  • Challenging complacency - embracing change and continuously improving work standards and business processes
  • Taking on new challenges

Its stringent adherence to quality, extensive marketing reach and premium packaging has enabled products to emerge as top brands in their respective segments. Some of its top-selling products are Brutacef, Nurokind Forte, Brutaflam, Hepakind, Gut-OK, Menohelp, Ubinext-LC, Rifastop, Ranidom-RD, Protijump, Gudgesic, Histakind & Magnatuss.

Magnet Labs aspires to create a healthier world with the vision of providing quality products at affordable prices has transformed into new ways of thinking, a new journey for growth and medical breakthroughs for patients.